MB

MPM BioImpact Portfolio holdings

AUM $611M
1-Year Est. Return 29.61%
This Quarter Est. Return
1 Year Est. Return
+29.61%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$704M
AUM Growth
+$37.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
54
New
Increased
Reduced
Closed

Top Buys

1
+$21M
2
+$18M
3
+$15.6M
4
CNTX icon
Context Therapeutics
CNTX
+$15.4M
5
REPL icon
Replimune Group
REPL
+$11.5M

Top Sells

1
+$15.6M
2
+$15.4M
3
+$10.4M
4
VKTX icon
Viking Therapeutics
VKTX
+$7.66M
5
NTLA icon
Intellia Therapeutics
NTLA
+$5.5M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$12.4M 1.76%
267,497
-27,433
27
$12.4M 1.76%
8,567,896
+2,926,002
28
$12.3M 1.75%
230,000
+58,895
29
$11.5M 1.63%
+950,000
30
$11.1M 1.57%
+4,164,178
31
$10.9M 1.55%
+257,788
32
$10.6M 1.51%
+414,035
33
$9.35M 1.33%
2,268,825
+235,784
34
$8.12M 1.15%
+23,000
35
$7.81M 1.11%
459,943
+240,435
36
$7.73M 1.1%
197,212
+31,412
37
$7.56M 1.07%
685,826
+206,374
38
$5.74M 0.81%
1,611,833
-184,917
39
$4.23M 0.6%
+50,000
40
$3.97M 0.56%
2,160,062
-672,002
41
$3.53M 0.5%
2,388,011
42
$3.45M 0.49%
+559,547
43
$3.35M 0.48%
1,106,851
-358,950
44
$2.79M 0.4%
+428,537
45
$2.75M 0.39%
5,095,912
46
$2.32M 0.33%
1,391,434
-1,018,428
47
$1.61M 0.23%
1,231,154
-408,695
48
– –
-896,915
49
– –
-330,000
50
– –
-72,395
1
2
3